Cardio-Kidney-Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease
Diabetes Obes Metab. 2026 Mar 12. doi: 10.1111/dom.70640. Online ahead of print.ABSTRACTAIMS: Kidney and cardiovascular diseases are highly prevalent among patients with Type 1 diabetes. To date, no randomised clinical trial has reported on the impact of novel cardio-kidney-metabolic (CKM) therapies

